Survey of Latin American ketogenic diet centers: Challenges and success for “La Terapia Cetogénica”
- 5 December 2024
- journal article
- research article
- Published by Wiley in Epileptic Disorders
- Vol. 27 (2) , 228-234
Abstract
Objective: Despite growing recognition of the efficacy of ketogenic diet therapies (KDT) in reducing seizure frequency and improving the quality of life for individuals with epilepsy, several factors hinder their widespread adoption across Latin America. Specific challenges in the region have been discussed but not formally studied. Currently, no data exist on the availability and operation of KDT teams in the region. To address this gap, we conducted a survey of KDT centers across Latin American countries in the framework of the biannual International Ketogenic Diet Conference in September 2023.Methods: A seven‐question survey was distributed via email to neurologists, dietitians, or through indexed publications.Results: Of the 16 centers approached, 14 (87.5%) responded, identifying 98 KDT centers. Nearly half (49%) are public institutions, primarily in Brazil, Chile, and Mexico; 44 are private; and 5 are mixed. Core teams in all centers included a neurologist and dietitian, with some teams in Argentina, Chile, and Paraguay also involving a medical nutritionist. None of the centers reported a protocol for transitioning to adult care, and consistent data on Glut1 patients and protocols were lacking.Significance: Over the past two decades, the KDT landscape in Latin America has improved, with established centers expanding and new ones emerging. However, continued efforts are needed to promote KDT adoption in countries where it is not yet practiced and in regions with limited resources and expertise.Keywords
This publication has 14 references indexed in Scilit:
- Unraveling unmet needs in ketogenic dietary services: An ERN EpiCARE surveyEpilepsia Open, 2024
- Telemedicine- versus outpatient-based initiation and management of ketogenic diet therapy in children with drug-resistant epilepsy during the COVID-19 pandemicSeizure: European Journal of Epilepsy, 2022
- Challenges in telemedicine for adult patients with drug-resistant epilepsy undergoing ketogenic diet treatment during the COVID-19 pandemic in the public healthcare system in BrazilEpilepsy & Behavior, 2020
- Collaborative scientific production of epilepsy in Latin America from 1989 to 2018: A bibliometric analysisHeliyon, 2020
- Telemedicine, drug-resistant epilepsy, and ketogenic dietary therapies: A patient survey of a pediatric remote-care program during the COVID-19 pandemicEpilepsy & Behavior, 2020
- Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendationsEpilepsy & Behavior, 2020
- Strategy and Plan of Action for Epilepsy 2018Epilepsy & Behavior, 2019
- Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study GroupEpilepsia Open, 2018
- What are the minimum requirements for ketogenic diet services in resource‐limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary TherapyEpilepsia, 2015
- Dietary therapies: A worldwide phenomenonEpilepsy Research, 2012